MedTrace Logo

THRIVE Apneic Ventilation With Standardized Airway Management During General Anesthesia.

NCT03797859 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2019-01-23

No results posted yet for this study

Summary

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) denotes the use of high-flow humidified nasal oxygen system (for example Optiflow®) as an alternative ventilation modality for an anesthetized patient without spontaneous respiration. This method requires only basic airway management manoeuvres to keep the airway open and provides both stable longterm oxygenation as well as apneic ventialtion.

We plan to evaluate this methods physiological performance under standardized conditions of airway management by frequent, repeated arterial blood gas analyses.

Conditions

  • Apnea
  • Ventilation Therapy; Complications
  • Respiratory Acidosis

Interventions

PROCEDURE

Apneic ventilation

Ventilation by THRIVE

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Michael S Kristensen, MD · Senior consultant, Rigshospitalet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-08
Primary Completion
2019-05-01
Completion
2019-06-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03797859 on ClinicalTrials.gov